BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 04, 2008
 |  BioCentury  |  Product Development

Velcade's history

Velcade's history

Date Event
1993 Harvard researchers found MyoGenics to target proteasome and focus on cachexia
1Q94 MyoGenics hires Julian Adams as head chemist
1Q94 Nobel Laureate Robert Huber crystallizes proteasome; publishes 3D structure
3Q94 Adams synthesizes the boronic acid analog proteasome inhibitor MG-341 (now Velcade)
1995 MyoGenics changes name to ProScript; focuses on inflammation

Read the full 342 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >